Atlas Trials

Dose-finding Study of MCI-196

Clinical trial NCT01814904 · TERMINATED

Trial details

NCT number
NCT01814904
Sponsor
Tanabe Pharma Corporation
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Kidney DiseaseDialysisHyperphosphatemiaPaediatric
Start date
2014-04-01
Primary completion
2015-01-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.